
NanoSynth Materials and Sensors Inc Profile last edited on: 8/5/16
CAGE: 6RLM6
UEI: FPU5ALK4R1V1
Business Identifier: Point-of-care (POC) diagnostic sensor: portable breathalyzer for tuberculosis Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 02
County: Salt Lake
Congr. District: 02
County: Salt Lake
Public Profile
Nanosynth Materials and Sensors develops and manufactures point-of-care (POC) diagnostic sensor technologies. POC diagnostic technologies have matured to the point where they can create tremendous value in health and healthcare. The firm is focused to designing diagnostic platforms to be fast -- generating a diagnostic result in less than 10 minutes -- portable, and cost effective. By integrating sensor technologies with a big data platform, management judge they will be able to provide real time disease mapping to predict the course of a disease, more effectively triage outbreaks, and track everything from patient compliance to treatment efficacy. A primary focus is on TB Detection
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2018 | 1 | NIH | $225,000 | |
Project Title: 1-D Titania Nanostructure Based Wearable Alcohol Sensor with Tunable Sensitivity and Artificial Intelligence | ||||
2015 | 1 | NSF | $225,000 | |
Project Title: Low Cost Point of Use Sensing and Mitigation of Pathogens in Drinking Water | ||||
2015 | 1 | NIH | $224,770 | |
Project Title: Rapid Monitoring and Assessment of Tubercuolosis Treatment At the Point of Care Using Breath | ||||
2013 | 1 | NSF | $222,316 | |
Project Title: Rapid Diagnosis of Tuberculosis at the Point of Care Using a Handheld Volatile Biomarker Sensor |
Key People / Management
Jason Young -- CEO
Krista Carlson
David D�angelo -- India Operations
Mohammad Rashed Khan
Mano Misra -- Chairman, Co-Founder, Advisor
Swomitra K Mohanty -- Chief Science Officer
David C Robinson -- Strategic Advisor
York Smith -- Research Associate
Krista Carlson
David D�angelo -- India Operations
Mohammad Rashed Khan
Mano Misra -- Chairman, Co-Founder, Advisor
Swomitra K Mohanty -- Chief Science Officer
David C Robinson -- Strategic Advisor
York Smith -- Research Associate
Company News
There are no news available.